<DOC>
	<DOCNO>NCT01955642</DOCNO>
	<brief_summary>Ischemic stroke ( AIC ) lead cause non-traumatic disability adult , second lead cause dementia third lead cause death France . Clopidogrel one recommend first line secondary prevention AIC non cardioembolic origin . However recurrences occur approximately 9 % patient receive clopidogrel . Some study patient coronary artery disease make connection treatment failures non-biological response clopidogrel . This non-biological response find approximately 30 % 50 % patient . Several mechanism may explain non-response . The accepted mechanism pharmacokinetic . Indeed , clopidogrel prodrug require intestinal absorption P-glycoprotein ( PGP ) transformation hepatic cytochrome active metabolite . The genetic polymorphism protein involve two step explain low plasma concentration active metabolite thus low efficacy clopidogrel patient . A new pharmacodynamic hypothesis suggest involvement platelet alpha 2-adrenergic receptor . The activation receptor potentiate signal pathway P2Y12 receptor ( channel inhibit clopidogrel ) help reduce platelet aggregation inhibit response clopidogrel .</brief_summary>
	<brief_title>Evaluation Biological Response Clopidogrel Patients With Ischemic Stroke</brief_title>
	<detailed_description>Interest biological response clopidogrel AIC innovative data available area . In addition test new pharmacodynamic hypothesis , also wish study compare measure platelet function method order able use commonly treatment decision .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Consent sign Patients noncardioembolic AIC require initiation treatment clopidogrel usual indication normal standard biological test Need continue aspirin therapy Patients recurrence clopidogrel AIC Patient already tack clopidogrel Drugs interfere adrenergic system alpha blocker , alpha 2 receptor agonist ( alphamethyldopa ) alpha2 receptor inhibitor ( Mianserin , Mirtazapine , yohimbine ) Contra indication clopidogrel / excipients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Brain Ischemia</keyword>
	<keyword>Ischemic attack</keyword>
	<keyword>Biological response clopidogrel</keyword>
</DOC>